Impairing Drugs and Alcohol as Risk Factors for Traumatic Injuries (IDART)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03773614|
Recruitment Status : Recruiting
First Posted : December 12, 2018
Last Update Posted : February 5, 2020
Impairing drugs and alcohol are major risk factors for traumatic injuries. Still there is to date little knowledge to what extent these factors affect the epidemiology of trauma. Detailed mapping of risk factors improve targeting and efficiency of primary injury prevention. The aim of this project is therefore to facilitate injury prevention through improved data collection and analysis on impairing drugs and alcohol as a contributing and modifiable factor in injury morbidity and mortality.
Study question: What is the toxicological profile among patients with suspected severe traumatic injury? Study design: a prospective population-based and national observational study will analyse toxicology from blood samples of all trauma admission during a 12 month study period.
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||8000 participants|
|Target Follow-Up Duration:||3 Weeks|
|Official Title:||Impairing Drugs and Alcohol as Risk Factors for Traumatic Injuries - a National Study on Injury Prevention|
|Actual Study Start Date :||March 1, 2019|
|Estimated Primary Completion Date :||February 29, 2020|
|Estimated Study Completion Date :||December 31, 2032|
- Presence of alcohol in blood samples. [ Time Frame: Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period. The database is analyzed after study period is completed. ]Alcohol is reported in grams per liter. Analysis of alcohol is performed with an automated enzymatic method using alcohol dehydrogenase.
- Presence of impairing illicit and medicinal drugs in blood samples. [ Time Frame: Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period. ]Impairing substances are reported as nanogram per milliliter. Analysis is performed using liquid chromatography coupled with mass spectrometry.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03773614
|Contact: Thomas Kristiansen, MD, PhD||(+47) email@example.com|
|Oslo, Norway, 0372|
|Contact: Thomas Kristiansen, MD, PhD 23070000 ext +47 firstname.lastname@example.org|